DePuy Synthes, the orthopedic arm of Johnson & Johnson, launched the Unium System for trauma and small bone procedures, according to a Nov. 22 news release.

The spine fusion device market is expected to reach almost $9 billion in the next six years, according to Emergen Research.

The FDA's Breakthrough Devices Program is designed to accelerate the development, assessment and review of medical devices that provide effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

Patient-specific implants, which tout more accurate spine and orthopedic surgery, have made several advances in 2021. Reception among surgeons remains mixed, however.

OsteoCentric Technologies acquired the Integrity Sacroiliac Fusion System.

Artificial disc replacement technology has made significant strides in 2021. Here's a breakdown of three artificial discs making headlines.

From Medtronic's new spine leader to Johnson & Johnson's planned split, here are eight key updates from spine and orthopedic device companies in the last week:

Aurora Spine reached a sales milestone in the third quarter, according to financial results posted Nov. 16.

Smith+Nephew will launch a digital surgery and robotics innovation center in Munich, Germany.

The American Medical Association accepted a new CPT add-on code for the second level of lumbar total disc replacement procedures.

Colfax, DJO's parent company, named its upcoming spinoff orthopedic brand, CEO Matt Trerotola said in a Nov. 4 third quarter earnings call.

Spineart USA's Baguera C cervical disc prosthesis has marked its 100th surgery in combined single-level and two-level U.S. investigational device exemption clinical trials.

NuVasive's stock jumped 9 percent Nov. 15 after a report that Globus Medical made a preliminary takeover approach, according to Seeking Alpha.

Accelus, a minimally invasive spine device company, plans to merge with CHP Merger Corp., according to a Nov. 15 news release.

Harry "Skip" Kiil has been appointed president of Medtronic's cranial and spinal technologies operating unit, effective Jan. 4.

Three new publicly traded device companies are expected to enter the market in the next one to two years, according to announcements from Zimmer Biomet, Johnson & Johnson and Colfax Corp.:

Johnson & Johnson is dividing into two separate companies; one will focus on its medical devices and drugs, and the other will focus on consumer health products.

From Johnson & Johnson's latest robotics acquisition to NuVasive's acquisition of an emerging spine technology, here are six medtech deals that caught the eye of readers in 2021.

From the CFO of Zimmer Biomet's spine and dental spinoff to MicroPort Orthopedics' medical director, here are eight leadership moves since Sept. 12:

Linnea Burman, vice president and general manager of Medtronic's enabling technology business, was recognized as Innovator of the Year by the National Spine Health Foundation.